Singapore, Jan. 14 -- Novotech CRO the largest biotech CRO in the Asia-Pacific said the region has had a record year for the number of studies, experienced world-class sites and investigators, and patient enrolment.

Novotech CRO released its Asia-Pacific Industry Data Highlights 2019-2020 at JP Morgan Healthcare Conference as part of its Biotech Industry Briefing session to more than 50 industry leaders wanting to know more about the benefits of conducting research in the Asia-Pacific.

The industry briefing will cover Asia's:

vast patient pools

high-quality infrastructure

lower trial concentration

comparable quality and lower costs

a key destination for biotech companies for later phase trials

Novotech CRO will also emphasize the ...